Aristocort A

Developed for: psoriasis
Investigated by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · University of Rochester

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Approved	US (FDA)	ARISTOCORT	—	1972-04-26	fda.gov ↗

Trials 1

today

US approved 1972

NCT00005922 · not/applicable

1971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT00005922	Aug 2000 → Jul 2006	psoriasis	University of Rochester	Completed	No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Aristocort A	“Dose of 0.025-0.05% of Aristocort A 2 times per day for a period of up to 14 weeks.” NCT00005922 ↗